EP Biocomposites Ltd. (EPBIO) — Tipsheet https://tipsheet.markets/company/epbio/ Every Tipsheet Editorial note covering EP Biocomposites Ltd. (EPBIO), newest first. Grounded in BSE/NSE primary-source filings. en-in Fri, 17 Jul 2026 22:32:02 GMT EP Biocomposites profit jumps 41.5% in FY26 https://tipsheet.markets/epbio-ep-biocomposites-profit-jumps-41-5-in-fy26-99145/ https://tipsheet.markets/epbio-ep-biocomposites-profit-jumps-41-5-in-fy26-99145/ Tue, 26 May 2026 17:40:15 GMT The company reported a net profit of ₹1.46 crore on revenue of ₹13.64 crore. Debt is down and the equity base is larger. The company reported a net profit of ₹1.46 crore on revenue of ₹13.64 crore. Debt is down and the equity base is larger.

What’s new

  • Net profit rose 41.5% to ₹1.46 crore for FY26.
  • Revenue grew 13.6% to reach ₹13.64 crore.
  • The balance sheet shows lower debt and a larger equity base.

Why it matters

Profit growth is outpacing revenue gains. This shows the company is keeping more of every rupee earned. A cleaner balance sheet provides a stable foundation for future operations.

What we’re watching

  • Whether the company maintains this profit growth rate.
  • Details on the specific debt reduction measures taken.
  • Management commentary on the revenue trajectory.

The full read

EP Biocomposites delivered a solid performance in FY26. Net profit rose 41.5% to ₹1.46 crore, while revenue grew 13.6% to ₹13.64 crore.

Profit growth is significantly higher than revenue growth, indicating the company is keeping more of its earnings while simultaneously cleaning up its balance sheet through debt reduction and a larger equity base.

It is a routine annual results filing.

The next test is whether the company can maintain this pace as it scales.

Primary source: BSE · NSE

]]> Earnings Tipsheet Editorial